BSW Wealth Partners’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $517K | Sell |
1,276
-181
| -12% | -$73.4K | 0.07% | 154 |
|
|
2025
Q1 | $725K | Buy |
1,457
+170
| +13% | +$84.6K | 0.11% | 110 |
|
|
2024
Q4 | $669K | Buy |
1,287
+56
| +5% | +$29.1K | 0.1% | 123 |
|
|
2024
Q3 | $762K | Buy |
1,231
+34
| +3% | +$21K | 0.11% | 96 |
|
|
2024
Q2 | $662K | Buy |
1,197
+72
| +6% | +$39.8K | 0.11% | 105 |
|
|
2024
Q1 | $654K | Sell |
1,125
-106
| -9% | -$61.6K | 0.11% | 110 |
|
|
2023
Q4 | $654K | Buy |
1,231
+23
| +2% | +$12.2K | 0.13% | 98 |
|
|
2023
Q3 | $612K | Sell |
1,208
-98
| -8% | -$49.6K | 0.14% | 92 |
|
|
2023
Q2 | $682K | Sell |
1,306
-1,184
| -48% | -$618K | 0.14% | 90 |
|
|
2023
Q1 | $1.44M | Buy |
2,490
+204
| +9% | +$118K | 0.29% | 51 |
|
|
2022
Q4 | $1.26M | Sell |
2,286
-31
| -1% | -$17.1K | 0.27% | 55 |
|
|
2022
Q3 | $1.18M | Buy |
2,317
+217
| +10% | +$110K | 0.29% | 43 |
|
|
2022
Q2 | $1.14M | Buy |
2,100
+345
| +20% | +$187K | 0.27% | 47 |
|
|
2022
Q1 | $1.04M | Buy |
1,755
+573
| +48% | +$339K | 0.26% | 51 |
|
|
2021
Q4 | $789K | Buy |
1,182
+69
| +6% | +$46.1K | 0.2% | 70 |
|
|
2021
Q3 | $636K | Sell |
1,113
-8
| -0.7% | -$4.57K | 0.18% | 79 |
|
|
2021
Q2 | $566K | Buy |
1,121
+198
| +21% | +$100K | 0.16% | 91 |
|
|
2021
Q1 | $421K | Buy |
923
+403
| +78% | +$184K | 0.12% | 104 |
|
|
2020
Q4 | $242K | Buy |
520
+7
| +1% | +$3.26K | 0.07% | 147 |
|
|
2020
Q3 | $226K | Buy |
+513
| New | +$226K | 0.08% | 128 |
|